Senseonics Holdings, Inc. Reports Second Quarter 2018 Financial Results

Go back to Senseonics Holdings, Inc. Reports Second Quarter 2018 Financial Results

Senseonics Holdings (SENS) Misses Q2 EPS by 9c, Revenues Miss

August 8, 2018 4:23 PM EDT

Senseonics Holdings (NYSE: SENS) reported Q2 EPS of ($0.23), $0.09 worse than the analyst estimate of ($0.14). Revenue for the quarter came in at $3.6 million versus the consensus estimate of $3.87 million.

Received FDA approval for the Eversense® CGM System, the first and only long-term implantable continuous glucose monitoring... More